Lung cancer screening has a significant impact on mortality rates for high-risk individuals, according to the results of a large randomized trial, NELSON, presented at the World Conference on Lung Cancer. The 10-year study found that low-dose CT screening decreased lung cancer mortality by as much as 61% in at-risk women, with a smaller—yet still significant—decrease of 26% for high-risk men.